Proofpoint,Inc. (NASDAQ:PFPT) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Appointment of President, Chief Operating Officer and Director
On July9, 2018, Proofpoint,Inc. (the “Company”) announced the appointment of Klaus Oestermann as President and Chief Operating Officer of the Company, effective immediately. The Board of Directors of the Company (the “Board”) has also appointed Mr.Oestermann to serve as a ClassII member of the Board, with a term expiring at the Company’s 2020 Annual Meeting of Stockholders, filling the vacancy created by Eric Hahn’s resignation from the Board.
Mr.Oestermann, 52, previously served as Senior Vice President and General Manager, Delivery Networks of Citrix Systems Inc. from February2015 to March2017. Prior to this appointment, Mr.Oestermann served as the Group Vice President and General Manager of Citrix’s Networking, Cloud and Service Provider group from January2010 to February2015, as Group Vice President and General Manager of the Netscaler and App Networking Product Group from December2006 to December2009 and as Area Vice President, US West from November2003 to December2006. Mr.Oestermann holds a graduate diploma (HD-A) in business administration from the Copenhagen Business School.
Compensatory Arrangements
The Company entered into an offer letter with Mr.Oestermann on July6, 2018 (the “Offer Letter”), in connection with his appointment as President and Chief Operating Officer. to the Offer Letter, Mr.Oestermann will receive an annual base salary of $500,000 and will be eligible to participate in the Company’s Executive Corporate Bonus Plan as it exists from time to time, with a target bonus opportunity of $500,000 for 2018, pro-rated for 2018 based on number of days employed.
In addition, Mr.Oestermann will receive:
· A time-based restricted stock unit award (the “RSU Grant”) having a value of $10 million. The RSU Grant will vest in annual installments over four years, beginning on the first anniversary of the grant date, subject to Mr.Oestermann’s continued service on each vesting date.
· A performance-based restricted stock unit award (the “PSU Grant”) having a value of $10 million, with $3 million of such PSU Grant to vest over a four-year period as follows: 50% of the PSU Grant (to the extent unvested) will become eligible to vest if, during the four-year “Performance Period” commencing on January1, 2018 (which is the Performance Period applicable to the current fiscal 2018 grants made to the executive team, in order to align Mr.Oestermann with the current executive team), the Company (a)has had 5 consecutive quarters of year on year revenue growth exceeding the pre-defined target percentage and (b)has achieved certain profitability metrics per the Board-approved operating plan cumulatively over the same five-quarter period. The remaining $7 million of such PSU grant will vest on the same terms, but with the four-year Performance Period commencing on July1, 2018.
For purposes of vesting calculations, the RSU Grant and the PSU Grant will have a grant date of July9, 2018, and the number of shares subject to the RSU Grant or the PSU Grant, as applicable, will be determined by dividing the value of the grant by the average closing price of the Company’s stock for the 30 trading days ending on the day before July9, 2018. The RSU Grant and the PSU Grant will be granted under the Company’s 2012 Equity Incentive Plan.
In the event of a termination of employment in a “Qualifying Termination,” as defined in the Change in Control and Severance Agreement (the “CICSA”) to be entered into by Mr.Oestermann and the Company, Mr.Oestermann will be entitled to receive (1)a lump sum cash payment in an amount equal to twelve months’ worth of Mr.Oestermann’s monthly base salary; (2)twelve months of acceleration of all outstanding equity awards (including with respect to any equity awards subject to performance-based vesting); provided that, performance-based awards shall only accelerate to the extent the applicable performance criteria are satisfied as of the date of termination (irrespective of whether a determination as to achievement has been made by termination), (3)50% of his target variable compensation, reduced by any portion of such variable compensation award otherwise paid to the following section (5)of this paragraph, (4)reimbursement of premiums paid for health care continuation coverage for up to twelve months, and (5)earned but unpaid annual bonus; in the case of amounts payable to sections (1)-(4)above, subject to a release of claims by Mr.Oestermann.